Serum S100-Beta as a Biomarker for Neurological Recovery in Acute Spinal Cord Injury (ASCI): A Prospective Case-Control Study
Cureus · 18.02.2025
DOI: 10.7759/cureus.79202 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Cureus, erschienen am 18.02.2025. Verfasst von Shah Waliullah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, King George's Medical University, Lucknow, IND. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, King George's Medical University, Lucknow, IND.
Zitieren
APA
Waliullah, S., Kumar, N., Kumar, B., Rastogi, D., Ara, Z., Raj, U., & Kumar, B. (2025). Serum S100-Beta as a Biomarker for Neurological Recovery in Acute Spinal Cord Injury (ASCI): A Prospective Case-Control Study. Cureus. https://doi.org/10.7759/cureus.79202
Vancouver
Waliullah S, Kumar N, Kumar B, Rastogi D, Ara Z, Raj U, et al. Serum S100-Beta as a Biomarker for Neurological Recovery in Acute Spinal Cord Injury (ASCI): A Prospective Case-Control Study. Cureus. 2025. doi:10.7759/cureus.79202
BibTeX
@article{Waliullah2025,
author = {Waliullah, Shah and Kumar, Nagendra and Kumar, Binod and Rastogi, Devarshi and Ara, Zeenat and Raj, Uday and Kumar, Bhavesh},
title = {Serum S100-Beta as a Biomarker for Neurological Recovery in Acute Spinal Cord Injury (ASCI): A Prospective Case-Control Study},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.79202}
}
EUVIMED